BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fleischmann D, Maslanka Figueroa S, Goepferich A. Steric Shielding of cRGD-Functionalized Nanoparticles from Premature Exposition to Off-Target Endothelial Cells under a Physiological Flow. ACS Appl Bio Mater 2021;4:640-50. [DOI: 10.1021/acsabm.0c01193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Bhushan NP, Stack T, Scott EA, Shull KR, Mathew B, Bijukumar D. In vitro assessment of varying peptide surface density on the suppression of angiogenesis by micelles displaying αvβ3 blocking peptides. J Biomed Mater Res B Appl Biomater 2023;111:343-53. [PMID: 36054456 DOI: 10.1002/jbm.b.35154] [Reference Citation Analysis]
2 Mattern A, Habermann S, Zegke M, Wickleder MS, Alberto R. High-Yield 99mTc Labeling of Gold Nanoparticles Carrying Atropine and Adrenaline. Bioconjug Chem 2022. [PMID: 35973128 DOI: 10.1021/acs.bioconjchem.2c00351] [Reference Citation Analysis]
3 Siani P, Frigerio G, Donadoni E, Di Valentin C. Molecular dynamics simulations of cRGD-conjugated PEGylated TiO2 nanoparticles for targeted photodynamic therapy. J Colloid Interface Sci 2022;627:126-41. [PMID: 35842963 DOI: 10.1016/j.jcis.2022.07.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ma B, Hu G, Guo S, Zeng Q, Chen Y, Hwan Oh D, Jin Y, Fu X. Use of Peptide-Modified Nanoparticles as a Bacterial Cell Targeting Agent for Enhanced Antibacterial Activity and Other Biomedical Applications. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111638] [Reference Citation Analysis]
5 Fleischmann D, Goepferich A. General sites of nanoparticle biodistribution as a novel opportunity for nanomedicine. Eur J Pharm Biopharm 2021;166:44-60. [PMID: 34087354 DOI: 10.1016/j.ejpb.2021.05.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]